Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
durable response to pembrolizumab plus axitinib in platinum resistant ovarian clear cell carcinoma a case report
Original title: “Durable response to pembrolizumab plus axitinib in platinum-resistant ovarian clear cell carcinoma: A case report.”
translation landscape of ovarian clear cell carcinoma indicates that rbm4 plays a pro oncogenic role in tumor progression
Original title: “The translation landscape of ovarian clear cell carcinoma indicates that RBM4 plays a pro-oncogenic role in tumor progression.”